Replies to post #197117 on Biotech Values

[DewDiligence]

NVO lowers long-term guidance:

http://www.reuters.com/article/novo-nordisk-results-idUSFWN15H06R

Novo Nordisk specified its 2016 guidance and lowered its target for long-term profit growth after a slightly weaker than expected fourth quarter.

…Long-term, the company sees annual growth in operating profit of 10 percent, down from an earlier target of 15 percent.

The global diabetes market has become considerably more competitive.